Novel use of (-)-epigallocatechin gallate

Abstract

An apparatus for generating a data stream having a series of segments using data organized in subsequent data frames, a data frame having more important and less important data. It comprises a packetiser for packetising data from a data frame into the series of segments having a first segment and a second segment, where the packetiser is operative to packetise the data of the frame so that a starting point of the more important data coincides with a starting point of the first segment and an information block adder for adding a first information block to the first segment.

1 - 10 . (canceled) 
   
   
       11 . A method for increasing the fat oxidation in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with an effective dose of a sympathomimeticum, to said mammal which is in need thereof at least half an hour before the intake of food, feed or beverage, containing said fat whose oxidation is increased, by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day. 
   
   
       12 . A method for supporting the metabolization of fat in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with an effective dose of a sympathomimeticum, to said mammal which is in need thereof at least half an hour before the intake of food, feed or beverage by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day. 
   
   
       13 . A method for reducing the fat mass in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof at least half an hour before the intake of food, feed or beverage by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, 
   
   
       14 . A method for reducing the weight of mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof at least half an hour before the intake of food, feed or beverage by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day. 
   
   
       15 . A method for reducing the carbohydrate oxidation in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof at least half an hour before the intake of food, feed or beverage, containing said carbohydrate whose oxidation is reduced, by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, 
   
   
       16 . The method according to  claim 11 , wherein said effective dose of (−)-epigallocatechin gallate is administered to said mammal at a point in time between half an hour and one and a half hour before the intake of food, feed or beverages. 
   
   
       17 . The method according to  claim 11 , further comprising the step of said mammal performing physical activity. 
   
   
       18 . A method for improving the flow mediated dilation in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, thereby contributing to a beneficial effect on the coronary health, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate to said mammal which is in need thereof, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day. 
   
   
       19 . The method according to  claim 11 , wherein the mammals are humans with a body mass index above 25. 
   
   
       20 . The method according to  claim 11 , wherein the (−)-epigallocatechin gaUate has a purity of at least 80%, preferably of at] least 85%, more preferably of at least 90%. 
   
   
       21 . A method for increasing the fat oxidation in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with an effective dose of a sympathomimeticum, to said mammal which is in need thereof before the intake of food, feed or beverage, containing said fat whose oxidation is increased, by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, and said method further comprising the step of said itiammal performing physical activity. 
   
   
       22 . A method for supporting the metabolization of fat in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with an effective dose of a sympathomimeticum, to said mammal which is in need thereof before the intake of food, feed or beverage by said mammal, characterized in mat the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, and said method further comprising the step of said mammal performing physical activity. 
   
   
       23 . A method for reducing the fat mass in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof before the intake of food, feed or beverage by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, morel preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, and said method further comprising the step of said mammal performing physical activity. 
   
   
       24 . A method for reducing the weight of mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof before the intake of food, feed or beverage by said mammal, characterized in that the effective dose of (-> epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, and said method further comprising the step of said mammal performing physical activity. 
   
   
       25 . A method for reducing the carbohydrate oxidation in mammals selected from the group consisting of humans, cats, dogs and horses, preferably in humans, said method comprising the step of administering an effective dose of (−)-epigallocatechin gallate, preferably in combination with a sympathomimeticum, to said mammal which is in need thereof before the intake of food, feed or beverage, containing said carbohydrate whose oxidation is reduced, by said mammal, characterized in that the effective dose of (−)-epigallocatechin gallate varies from 0.14 to 25 mg per kg body weight per day, preferably from 2.0 to 9 mg per kg body weight per day, more preferably from 4.0 to 9.0 mg per kg body weight per day, most preferably from 4.0 to 4.5 mg per kg body weight per day, and said method further comprising the step of said mammal performing physical activity.